House Positions for C:ACB from 20181212 to 20181212

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
53 Morgan Stanley	700,581	5,729,765	8.179	41,069	334,962	8.156	659,512	-5,394,803
79 CIBC	6,401,933	52,352,836	8.178	5,806,176	47,476,882	8.177	595,757	-4,875,954
14 ITG	284,945	2,335,979	8.198	70,000	568,848	8.126	214,945	-1,767,131
85 Scotia	1,668,827	13,657,569	8.184	1,476,028	12,066,726	8.175	192,799	-1,590,843
62 Haywood	49,700	401,038	8.069	500	4,050	8.10	49,200	-396,988
1 Anonymous	5,920,151	48,475,774	8.188	5,873,354	48,046,024	8.18	46,797	-429,750
72 Credit Suisse	40,410	330,704	8.184	22	179	8.136	40,388	-330,525
28 BBS	75,056	611,446	8.147	34,750	284,347	8.183	40,306	-327,099
88 Credential	279,167	2,288,443	8.197	239,692	1,953,753	8.151	39,475	-334,690
143 Pershing	37,302	304,912	8.174	23,462	192,329	8.197	13,840	-112,583
99 Jitney	346,750	2,842,763	8.198	336,800	2,755,163	8.18	9,950	-87,600
57 Interactive	27,050	221,326	8.182	18,666	151,252	8.103	8,384	-70,074
89 Raymond James	10,000	82,000	8.20	2,045	16,761	8.196	7,955	-65,239
22 Fidelity	6,740	54,400	8.071	0			6,740	-54,400
83 Mackie	4,080	33,413	8.189	0			4,080	-33,413
56 Edward Jones	1,320	10,703	8.108	225	1,857	8.253	1,095	-8,846
76 Industrial Alliance	1,000	8,232	8.232	0			1,000	-8,232
68 Leede	2,900	23,755	8.191	2,800	22,836	8.156	100	-919
74 GMP	2,000	16,380	8.19	1,980	16,196	8.18	20	-184
48 Laurentian	700	5,782	8.26	700	5,680	8.114	0	-102
35 Friedberg	1,000	8,060	8.06	1,000	8,130	8.13	0	70
101 SG Capital	27,834	226,991	8.155	28,100	230,656	8.208	-266	3,665
36 Latimer	2,500	20,393	8.157	3,000	24,240	8.08	-500	3,847
200 Acumen	0			2,300	18,768	8.16	-2,300	18,768
222 JP Morgan	2,471	20,337	8.23	6,695	54,563	8.15	-4,224	34,226
17 Integral	2,000	16,340	8.17	6,500	53,420	8.218	-4,500	37,080
70 Manulife	0			7,090	58,278	8.22	-7,090	58,278
15 UBS	700	5,728	8.183	9,000	73,750	8.194	-8,300	68,022
8 Eight	62,000	495,563	7.993	80,000	647,664	8.096	-18,000	152,101
65 Goldman	505,945	4,138,120	8.179	534,131	4,367,865	8.178	-28,186	229,745
19 Desjardins	150,446	1,224,827	8.141	194,415	1,593,943	8.199	-43,969	369,116
90 Barclays	94,400	778,759	8.25	139,900	1,141,789	8.161	-45,500	363,030
97 M Partners	0			50,000	405,250	8.105	-50,000	405,250
73 Cormark	0			50,000	409,002	8.18	-50,000	409,002
124 Questrade	322,413	2,636,511	8.177	388,006	3,171,639	8.174	-65,593	535,128
7 TD Sec	4,655,585	38,059,436	8.175	4,734,398	38,740,878	8.183	-78,813	681,442
80 National Bank	329,459	2,689,549	8.164	419,281	3,431,851	8.185	-89,822	742,302
33 Canaccord	392,937	3,187,454	8.112	506,777	4,133,362	8.156	-113,840	945,908
13 Instinet	762,497	6,227,230	8.167	877,203	7,162,776	8.165	-114,706	935,546
9 BMO Nesbitt	621,455	5,078,486	8.172	757,026	6,184,494	8.169	-135,571	1,106,008
39 Merrill Lynch	1,972,175	16,158,234	8.193	2,429,855	19,899,043	8.189	-457,680	3,740,809
2 RBC	2,788,654	22,806,946	8.178	3,402,137	27,856,978	8.188	-613,483	5,050,032
TOTAL	28,555,083	233,566,184	8.179	28,555,083	233,566,184	8.179	0	0

Haywood analyst Neal Gilmer APHA TARGET $17.00

Haywood analyst Neal Gilmer APHA TARGET $17.00 says he does not believe the report is accurate in its entirety. In return, Gilmer reiterates a Buy rating, but does drop down his price target from $30 to $17 to “reflect current market sentiment.” (To watch Gilmer’s track record, click here)

“Following the release of reports of this nature, companies often trade at a discount due to an increase perceived risk by investors, regardless of the accuracy of the claims in the short report. As a result, we are lowering our target price to $17.00 based on a 2021 EBITDA multiple of 15x discounted by 10%. We continue to believe that Aphria provides a compelling investment both on its domestic operations and the optionality provided by the international opportunities. However, it is clear that investors are putting more faith in the authors of the short report. While we acknowledge that it will take time for Aphria to emerge from this report, we remain of the view that the Company has solid domestic operations and an expanding international footprint. We believe this sell-off provides an attractive entry point for risk tolerant investors as we expect volatility to be escalated in the near-term,” Gilmer said.

Read more at 

http://www.stockhouse.com/companies/bullboard/t.apha/aphria-inc?postid=29103888#81rS8yOTwWrzOAT1.99